AI-ECG-TIMINCT06528821
AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Mar 16, 2026 to Sep 30, 2026 Show 6 more changesShow less
- Eligibility criteria expanded, about 7 words
- Trial completed
- Final enrollment: 718 participants (planned 800)
- Study completion date changed from estimate of May 16, 2026 to Sep 30, 2026
- Secondary endpoints: details revised at 5 of 6 entries
- Site details revised at 1 of 9 sites
- Minor Trial status: Recruiting to Active, Not Recruiting
- Primary completion date changed from estimate of Oct 1, 2025 to Mar 16, 2026
- Study completion date: Oct 1, 2025 to May 16, 2026
- Site details revised at 9 of 9 sites
- Minor Study sites: 4 to 9v4
- Minor Trial status: Enrolling by Invitation to Recruiting
- Site details revised at 4 of 4 sites
- Notable Primary and study completion dates pushed to Oct 1, 2025
- Study sites: 1 to 4
- Start date changed from estimate of Sep 15, 2024 to Dec 10, 2024
- Secondary endpoints: details revised at 6 of 6 entries
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Diagnostic Accuracy of the AI-ECG TIMI AI Model
Timeframe: Index hospitalization (assessed up to 5 days)
Secondary (6)
Subgroup Performance
Correlate established definitions of occlusion myocardial infarction (OMI) to myocardial perfusion status
ECG prediction of mechanical reperfusion
Assessment of expert ECG interpretation blinded to all clinical information
STEMI-equivalent ECG patterns
Show 1 moreShow less
Subgroup analysis of NSTEMI-OMI patients
Sites
9 sites in 3 countries
Austria 3, Belgium 3, Italy 3